Radio‐opaque fecal impaction and pseudo‐occlusion in a dialyzed patient taking lanthanum carbonate
Authors:
- 28 November 2011
- journal article
- case report
- Published by Wiley in Hemodialysis International
- Vol. 16 (4) , 556-558
Abstract
Lanthanum therapy is an efficient therapy of hyperphosphoremia by chelating phosphore in the digestive tract. Lanthanum is a silvery white metallic element that belongs to group 3 of the periodic table. This drug is lightly absorbed and has low water solubility. It should be borne in mind that abdominal X‐rays of patients taking lanthanum carbonate may have a radio‐opaque appearance typical of imaging agents. This characteristic is suggested to confirm adherence of the patient by doing an abdominal X‐ray. We describe in our case a particular good compliant patient with slow digestive transit, which ends by pseudo‐occlusion.Keywords
This publication has 11 references indexed in Scilit:
- Encephalopathy caused by lanthanum carbonateClinical Kidney Journal, 2011
- Colonic Opacification in a Patient With End-Stage Kidney DiseaseGastroenterology, 2010
- Accumulation of lanthanum carbonate in the digestive tractsClinical and Experimental Nephrology, 2009
- A confusional state associated with use of lanthanum carbonate in a dialysis patient: a case reportNephrology Dialysis Transplantation, 2009
- Hepatocellular transport and gastrointestinal absorption of lanthanum in chronic renal failureKidney International, 2009
- Lanthanum carbonate possibly responsible for acute liver failure in a patient with Child-Pugh stage A liver cirrhosis.Clinical Kidney Journal, 2008
- Systemic lanthanum is excreted in the bile of ratsToxicology Letters, 2007
- Absolute Bioavailability and Disposition of Lanthanum in Healthy Human Subjects Administered Lanthanum CarbonateThe Journal of Clinical Pharmacology, 2006
- Evolution of bone and plasma concentration of lanthanum in dialysis patients before, during 1 year of treatment with lanthanum carbonate and after 2 years of follow-upNephrology Dialysis Transplantation, 2006
- Chronic renal failure is associated with increased tissue deposition of lanthanum after 28-day oral administrationKidney International, 2005